Announcements
- ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
- ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des Jahres
- ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écoulée
- ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
- ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine
- ONWARD® Medical veranstaltet Webcast zu Einzelheiten der Up-LIFT-Studie und der aktuellen Veröffentlichung in Nature Medicine
- Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® Therapy
- Nature Medicine hebt signifikante Verbesserung der Hand- und Armfunktion nach einer Rückenmarksverletzung durch die ONWARD® ARC-EX® Therapie hervor
- ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication
- Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy
More ▼
Key statistics
On Friday, ONWARD Medical NV (63E:MUN) closed at 5.08, -21.85% below its 52-week high of 6.50, set on Feb 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.08 |
---|---|
High | 5.08 |
Low | 5.08 |
Bid | 4.73 |
Offer | 4.89 |
Previous close | 5.16 |
Average volume | 373.40 |
---|---|
Shares outstanding | 34.63m |
Free float | 28.07m |
P/E (TTM) | -- |
Market cap | 166.56m EUR |
EPS (TTM) | -1.20 EUR |
Data delayed at least 15 minutes, as of Jun 14 2024 07:05 BST.
More ▼